Filed |
Name |
|
Company |
Pur. £ |
Cur. £ |
P/L % |
MPV* |
Apr '10
|
Lord Lloyd-Webber
|
|
Idexx Labs / NMS:IDXX |
£29.96
|
£409.03
|
1,265.25%
|
£955,677.60
|
Jan '13
|
Lord Glendonbrook
|
|
Waters / NYQ:WAT |
£87.09
|
£360.63
|
314.09%
|
£289,862.23
|
Aug '17
|
Lord Sterling of Plaistow
|
|
Danaher / NYQ:DHR |
£71.88
|
£226.16
|
214.64%
|
£220,246.59
|
Jul '16
|
Lord Glendonbrook
|
|
Danaher / NYQ:DHR |
£72.15
|
£226.16
|
213.44%
|
£219,407.70
|
Aug '18
|
Lord Carter of Coles
|
|
Danaher / NYQ:DHR |
£90.94
|
£226.16
|
148.69%
|
£174,084.56
|
May '18
|
Lord Green of Hurstpierpoint
|
|
Thermo Fisher Scientific / NYQ:TMO |
£215.97
|
£516.69
|
139.24%
|
£167,469.09
|
May '19
|
Lord Sterling of Plaistow
|
|
Mettler Toledo / NYQ:MTD |
£701.77
|
£1,481.07
|
111.05%
|
£147,733.44**
|
Feb '19
|
Lord Carter of Coles
|
|
Mettler Toledo / NYQ:MTD |
£672.49
|
£1,206.02
|
79.34%
|
£125,535.55
|
Aug '20
|
Lord Sterling of Plaistow
|
|
Thermo Fisher Scientific / NYQ:TMO |
£416.17
|
£516.69
|
24.15%
|
£86,907.51
|
Sep '20
|
Lord Carter of Coles
|
|
Thermo Fisher Scientific / NYQ:TMO |
£418.14
|
£516.69
|
23.57%
|
£86,498.06
|
Nov '23
|
Lord Mance
|
|
Thermo Fisher Scientific / NYQ:TMO |
£459.24
|
£516.69
|
12.51%
|
£78,756.86
|
Apr '22
|
Lord Grabiner
|
|
Danaher / NYQ:DHR |
£248.88
|
£226.16
|
-9.13%
|
£63,609.01
|
Apr '22
|
Lord Grabiner
|
|
Thermo Fisher Scientific / NYQ:TMO |
£570.94
|
£516.69
|
-9.50%
|
£63,348.69
|
Apr '22
|
Lord Cromwell
|
|
Danaher / NYQ:DHR |
£245.55
|
£201.40
|
-17.98%
|
£57,414.25**
|
Sep '23
|
Lord Nash
|
|
Abingdon / LSE:ABDX.L |
£11.25
|
£7.75
|
-31.11%
|
£48,222.22
|
Oct '20
|
Lord Glendonbrook
|
|
Bds / NGM:BDSX |
£12.81
|
£1.36
|
-89.38%
|
£7,431.69
|
Jun '22
|
Lord Stevens of Ludgate
|
|
Verici Dx / LSE:VRCI.L |
£26.00
|
£2.63
|
-89.90%
|
£7,067.31
|
* Minimum Potential Value based on £70,000.00 invested at time of declaration.
** Interest ceased/exited on filed date.